FDA Grants Orphan Drug Status to Sanofi's Rilzabru...
Category : ODD/BTA/FTA Status 5 June 2025The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, a no...
Odd Bta Fta Status
FDA Grants Breakthrough Status to Tinlarebant for...
Category : ODD/BTA/FTA Status 24 May 2025Belite Bio, Inc., a clinical-stage biopharmaceutical company focused on treating degenerative retina...
Alterity’s ATH434 Gets FDA Fast Track for Multiple...
Category : ODD/BTA/FTA Status 6 May 2025Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...
OKYO Pharma’s Urcosimod Gets FDA Fast Track for Co...
Category : ODD/BTA/FTA Status 5 May 2025OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announces that the US Food...
Baebies Gets FDA Breakthrough Status for Heparin M...
Category : ODD/BTA/FTA Status 26 April 2025Baebies, a North Carolina-based diagnostics company, has received Breakthrough Device Designation fr...
Latest Newsletter Post
-
Innovent completes first patient do..
18 June 2025
-
Skyhawk Therapeutics Announces SKY-..
18 June 2025
-
Ascletis Doses First Participants i..
18 June 2025
-
Emory & Micron Start First Human Tr..
18 June 2025
-
EVEREST phase 4 study of Dupixent s..
18 June 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com